The Race to Test, Produce and Distribute a Coronavirus Vaccine
The global quest for a coronavirus vaccine is heating up. Moderna, a Masschusetts-based biotechnology company, announced promising results this week from a limited early trial of its vaccine candidate. And last Friday, President Donald Trump unveiled “Operation Warp Speed,” a new public-private partnership that aims to make a vaccine available in substantial quantities by the end of the year.
For this week’s interview on Trend Lines, WPR’s Elliot Waldman is joined by Paul Offit, a physician and director of the Vaccine Education Center at the Children’s Hospital of Pennsylvania, to discuss what it will take to safely manufacture—and fairly distribute—a coronavirus vaccine.
Relevant Articles on WPR:
A Divided America Can’t Win the ‘War’ Against the Coronavirus
Fighting Over Limited Medical Supplies Is No Way to Respond to COVID-19
How ‘Medical Nationalism’ Is Undermining the Fight Against the Coronavirus Pandemic
If you like what you hear on Trend Lines and what you’ve read on WPR, you can sign up for our free newsletter to get our uncompromising analysis delivered straight to your inbox. The newsletter offers a free preview article every day of the week, plus three more complimentary articles in our weekly roundup every Friday. Sign up here. Then subscribe.
Trend Lines is produced and edited by Peter Dörrie, a freelance journalist and analyst focusing on security and resource politics in Africa. You can follow him on Twitter at @peterdoerrie.
To send feedback or questions, email us at email@example.com.